WEKO3
アイテム
Clinical trial of photodynamic therapy for peripheral-type lung cancers using a new laser device in a pilot study
https://repo.qst.go.jp/records/80288
https://repo.qst.go.jp/records/80288302e1905-c666-4cf7-a0cd-7a1b88ecdd78
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-08-04 | |||||
タイトル | ||||||
タイトル | Clinical trial of photodynamic therapy for peripheral-type lung cancers using a new laser device in a pilot study | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Usuda, Jitsuo
× Usuda, Jitsuo× Inoue, Tatsuya× Tsuchida, Takaaki× Ohtani, Keishi× Maehara, Sachio× Ikeda, Norihiko× Ohsaki, Yoshinobu× Sasaki, Takaaki× Oka, Kiyoshi× Oka, Kiyoshi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Introduction/Aim Photodynamic therapy (PDT) involves the use of a tumor-specific photosensitizer and laser irradiation, and is one of the treatment options recommended for early centrally located lung cancers, but not yet for peripheral-type lung cancers. We developed a new laser probe, the composite-type optical fiberscope (COF), which allows accurate laser irradiation of a cancer lesion with simultaneous visualization of the lesion. In this study, we attempted a new endobronchial PDT technique using the new laser probe, and evaluated the effectiveness and feasibility of this novel PDT technique for peripheral lung cancers. Methods This phase I study was conducted in 7 patients with peripheral lung cancers (primary tumor ≤20 mm in diameter). We performed endobronchial PDT for these patients using the new laser probe and talaporfin sodium as the photosensitizer. Results We performed PDT for 3 patients with peripheral lung cancer using a laser dose of 50 J/cm2 at 120 mW, and confirmed the feasibility of using this dose. Then, we escalated the laser dose to 100 J/cm2 in 4 additional patients. A total of 7 patients met our inclusion criteria. Evaluation at 2 weeks and 3 months after the PDT revealed no complication such as pneumonia or pneumothorax. At the evaluation conducted 6 months later, we found CR in 3 cases and SD in the remaining 4 cases. Conclusion PDT was found to be a feasible and non-invasive treatment modality for early peripheral-type lung cancer. In the future, PDT could become a standard treatment option for peripheral-type lung cancer. |
|||||
書誌情報 |
Photodiagnosis and Photodynamic Therapy 巻 30, 発行日 2020-06 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1572-1000 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.pdpdt.2020.101698 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.sciencedirect.com/science/article/abs/pii/S157210002030051X#! |